Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $104
LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. LMAT | 0.00 |
Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:
LMAT) with a Equal-Weight and raises the price target from $94 to $104.